Educational guide
LGD-4033 and Testosterone Interaction: Monitor | Peptide Database
Compound Profiles LGD-4033 Selective Androgen Receptor Modulator | Lean Mass LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its t
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Compound Profiles
LGD-4033
Selective Androgen Receptor Modulator | Lean Mass
LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.
Testosterone
Anabolic-Androgenic Steroid | Primary Male Sex Hormone
Testosterone exerts its effects primarily through binding to the intracellular androgen receptor (AR), forming a hormone-receptor complex that translocates to the nucleus and modulates gene transcription. This drives protein synthesis in skeletal muscle (anabolic effect), stimulates erythropoietin production in the kidneys to increase red blood cell mass, promotes osteoblast activity and bone mineral density, and regulates libido and cognitive function.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take LGD-4033 with Testosterone?
Yes, but with caution. LGD-4033 causes dose-dependent suppression of endogenous testosterone through HPG axis negative feedback. Some users run a low-dose testosterone base (e.g., 100-150 mg/week TRT) alongside LGD-4033 to prevent suppression-related side effects such as low libido, lethargy, fatigue, and mood disturbance. If combining, monitor total testosterone, free testosterone, estradiol, and SHBG levels. Adding exogenous testosterone converts this from a SARM-only cycle to a testosterone cycle with regulatory and health implications. Regular monitoring is advised.
Is LGD-4033 and Testosterone safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: androgenic, carcinogenic risk, estrogenic, hepatotoxic, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.
What are the interactions between LGD-4033 and Testosterone?
LGD-4033 causes dose-dependent suppression of endogenous testosterone through HPG axis negative feedback. Some users run a low-dose testosterone base (e.g., 100-150 mg/week TRT) alongside LGD-4033 to prevent suppression-related side effects such as low libido, lethargy, fatigue, and mood disturbance. If combining, monitor total testosterone, free testosterone, estradiol, and SHBG levels. Adding exogenous testosterone converts this from a SARM-only cycle to a testosterone cycle with regulatory and health implications. This assessment has 90% confidence and is based on documented research data.
How should I time LGD-4033 and Testosterone?
LGD-4033 has a half-life of ~24-36 hours and Testosterone has a half-life of ~8 days (cypionate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.